Screen time solution? gummy vitamins may boost Kids' eyes and brain
NCT ID NCT07355725
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether Lutemax 2020 gummies, containing lutein and zeaxanthin, could improve vision and cognitive performance in children aged 5 to 12 who spend at least 4 hours daily on digital devices. Sixty children were randomly assigned to receive either the supplement or a placebo for about 6 months. Researchers measured changes in macular pigment density, visual processing speed, and contrast sensitivity to see if the supplement helped counteract the effects of heavy screen time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Lutemax 2020 (lutein and zeaxanthin) gummies
What this could lead to
If it works, this could point toward a simple supplement to help protect children's eyesight and mental focus from too much screen time.
What could go wrong
This is a small, completed study with only 60 children, so results may not apply to everyone. Dietary supplements often show modest effects, and the placebo effect could play a role.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sanjeevini Netralaya
Bangalore, Karnataka, 560001, India